Maximizing the benefits of using biosimilars in Egypt

Ahmad Nader Fasseeh1 Syreon Middle EastAlexandriaEgypt;2 Faculty of Pharmacy, Alexandria UniversityAlexandriaEgyptCorrespondence[email protected]

Baher Elezbawy1 Syreon Middle EastAlexandriaEgypt

Kareem Ahmed El-Fass1 Syreon Middle EastAlexandriaEgypt

Mary GamaI3 Egyptian Authority for Unified Procurement, Medical Supply and Technology ManagementCairoEgypt

Ahmed Seyam4 Universal Health Insurance AuthorityCairoEgypt

Noha Hayek5 Theodor Bilharz Research InstituteGizaEgypt

Nagwan Abdel Rahman6 Health Insurance OrganizationCairoEgypt

Sohir Abdelhamid7 Egyptian Parliament Health SectorCairoEgypt

Nader Fasseeh8 Faculty of Medicine, Alexandria UniversityAlexandriaEgypt

Amr Shafik Saad9 Faculty of Medicine, Ain Shams UniversityCairoEgypt

Ahmed Elagamy3 Egyptian Authority for Unified Procurement, Medical Supply and Technology ManagementCairoEgypt

Akram Mahmoud6 Health Insurance OrganizationCairoEgypt

Amal Samir Sedrak4 Universal Health Insurance AuthorityCairoEgypt;10 Faculty of MedicineCairo UniversityCairoEgypt

Khaled Elshazly11 Presidential Program for Women’s HealthCairoEgypt

Mariam Eldebeiky3 Egyptian Authority for Unified Procurement, Medical Supply and Technology ManagementCairoEgypt

Monica Talaat12 Egyptian Drug AuthorityCairoEgypt

Noura Maher Mohamed4 Universal Health Insurance AuthorityCairoEgypt

Rania Ahmed Abdelaziz4 Universal Health Insurance AuthorityCairoEgypt

Remonda Refaat3 Egyptian Authority for Unified Procurement, Medical Supply and Technology ManagementCairoEgypt

Shaimaa Akeel3 Egyptian Authority for Unified Procurement, Medical Supply and Technology ManagementCairoEgypt

Sherif Abaza1 Syreon Middle EastAlexandriaEgypt

Zoltán Kaló13 Semmelweis UniversityBudapestHungary;14 Syreon Research InstituteBudapestHungary

Your download is now in progress and you may close this window